在初级肝癌治疗中,利用基因组学,分子生物标志物和人工智能进行范式转变
James Moroney1, Juan Trivella2, Ben George3
1Division of Vascular and Interventional Radiology, Department of Radiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Cancers
|June 22, 2023
概括
本综述涵盖了初级肝癌治疗的进展,包括基因组学,生物标志物和人工智能. 它强调了免疫疗法和本地区域治疗这种复杂疾病的新方向.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物技术是生物技术.
背景情况:
- 原发性肝癌是全球主要的健康问题,在发病率上排名第六,死亡率排名第三.
- 传统治疗的疗效有限,这强调了需要新的治疗策略.
研究的目的:
- 审查初级肝癌治疗的最新突破.
- 探索基因组学,分子生物标志物和人工智能在治疗进步中的作用.
- 讨论免疫疗法和局部区域疗法的未来方向.
主要方法:
- 对初级肝癌当前研究的文献综述.
- 分析癌症基因组学和生物标志物发现的新兴趋势.
- 检查人工智能在瘤学中的应用.
主要成果:
- 基因组和分子分析正在揭示新的治疗点.
- 人工智能在改善诊断和治疗选择方面表现有前途.
- 免疫疗法和先进的局部区域疗法正在迅速发展.
结论:
- 整合基因组学,生物标志物和人工智能对于个性化初级肝癌治疗至关重要.
- 进一步研究免疫疗法和精细的局部区域方法具有显著的潜力.
- 解决肝癌的复杂性需要一个多学科和创新的治疗策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
